OPKO Health, Inc. (NAS: OPK) Stock Analysis & Fundamentals | ScreenerHero

Create free account

OPKOPKO Health, Inc.

NAS · US · Healthcare · Diagnostics & Research · opko.com

1.500USD-0.66%Mkt Cap: 1.13B $P/E: —1d ago

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutic…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/B

Cheaper

1M Perf

Avg

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap1.13B $

Enterprise Value1.20B $

Revenue (TTM)581.12M $

Gross Profit205.94M $

Net Income (TTM)-225.68M $

Revenue/Share0.7520 USD

Last Price1.500 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees2.3K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS68375N1037

Valuation

P/E (Trailing)—

P/E (Forward)-4.69

PEG93.65

EV/EBITDA-10.65

EV/Revenue2.06

P/S1.95

P/B0.94

EPS (TTM)-0.27

EPS (Forward)-0.32

52W Range

0.980083% of range1.605

52W High1.605 USD

52W Low0.9800 USD

Profitability

Gross Margin33.93%

Oper. Margin-41.08%

EBITDA Margin-19.36%

Profit Margin-37.19%

ROE-17.80%

ROA-11.68%

Growth

Revenue Growth-17.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-178.54M $

CapEx (TTM)12.28M $

FCF Margin-6.21%

FCF Yield-3.19%

Net Debt65.06M $

Net Debt/EBITDA-0.58

Balance Sheet

Debt/Equity0.31

Current Ratio3.61

Quick Ratio2.83

Book Value/Sh1.595 USD

Cash/Share0.4390 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.0 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)4.375 USD

Upside (mean)+191.7%

Target Range3.000 USD – 8.500 USD

$3.000+191.7% to mean$8.500

# Analysts4

Ownership

Shares Out.755.09M

Float332.68M

Insiders49.49%

Institutions27.16%

Short Interest

Short Ratio11.3d

Short % Float7.74%

Short % Out.4.34%

Shares Short32.79M

Short (prev mo.)32.66M

Technical

SMA 501.294 (+15.9%)

SMA 2001.310 (+14.5%)

Beta1.49

S&P 52W Chg20.05%

Avg Vol (30d)2.86M

Avg Vol (10d)3.70M

Technical Indicators

RSI (14)65.8

MACD0.0567

MACD Signal0.0567

MACD Hist.+0.0001

BB Upper1.532 USD

BB Middle1.449 USD

BB Lower1.366 USD

BB Width11.47%

ATR (14)0.0637 USD

Vol Ratio (20d)0.65x